218 related articles for article (PubMed ID: 17194441)
1. Anti-enterovirus activity and structure-activity relationship of a series of 2,6-dihalophenyl-substituted 1H,3H-thiazolo[3,4-a]benzimidazoles.
De Palma AM; Heggermont W; Leyssen P; Pürstinger G; Wimmer E; De Clercq E; Rao A; Monforte AM; Chimirri A; Neyts J
Biochem Biophys Res Commun; 2007 Feb; 353(3):628-32. PubMed ID: 17194441
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory properties of 2-substituent-1H-benzimidazole-4-carboxamide derivatives against enteroviruses.
Xue F; Luo X; Ye C; Ye W; Wang Y
Bioorg Med Chem; 2011 Apr; 19(8):2641-9. PubMed ID: 21441033
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antiviral activity against Coxsackie virus B3 of some novel benzimidazole derivatives.
Cheng J; Xie J; Luo X
Bioorg Med Chem Lett; 2005 Jan; 15(2):267-9. PubMed ID: 15603937
[TBL] [Abstract][Full Text] [Related]
4. 9-Arylpurines as a novel class of enterovirus inhibitors.
Aguado L; Thibaut HJ; Priego EM; Jimeno ML; Camarasa MJ; Neyts J; Pérez-Pérez MJ
J Med Chem; 2010 Jan; 53(1):316-24. PubMed ID: 19924996
[TBL] [Abstract][Full Text] [Related]
5. Anti-HIV agents. I: Synthesis and in vitro anti-HIV evaluation of novel 1H,3H-thiazolo[3,4-a]benzimidazoles.
Chimirri A; Grasso S; Monforte AM; Monforte P; Zappalà M
Farmaco; 1991 Jun; 46(6):817-23. PubMed ID: 1685321
[TBL] [Abstract][Full Text] [Related]
6. Anti-HIV agents. IV. Synthesis and in vitro anti-HIV activity of novel 1-(2,6-difluorophenyl)-1H,3H-thiazolo[3,4-a]benzimidazoles.
Chimirri A; Grasso S; Molica C; Monforte AM; Monforte P; Zappalà M; Scopelliti R
Farmaco; 1996 Apr; 51(4):279-82. PubMed ID: 8645416
[No Abstract] [Full Text] [Related]
7. Antirhino/enteroviral vinylacetylene benzimidazoles: a study of their activity and oral plasma levels in mice.
Tebbe MJ; Spitzer WA; Victor F; Miller SC; Lee CC; Sattelberg TR; McKinney E; Tang JC
J Med Chem; 1997 Nov; 40(24):3937-46. PubMed ID: 9397174
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, antiviral and antitumor activity of 2-substituted-5-amidino-benzimidazoles.
Starcević K; Kralj M; Ester K; Sabol I; Grce M; Pavelić K; Karminski-Zamola G
Bioorg Med Chem; 2007 Jul; 15(13):4419-26. PubMed ID: 17482821
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships of antitumor thiazolo[3,4-a]benzimidazole derivatives.
Chimirri A; Grasso S; Montforte AM; Montforte P; Zappalà M; Carotti A
Farmaco; 1994 May; 49(5):337-44. PubMed ID: 8080616
[TBL] [Abstract][Full Text] [Related]
10. New pleconaril and [(biphenyloxy)propyl]isoxazole derivatives with substitutions in the central ring exhibit antiviral activity against pleconaril-resistant coxsackievirus B3.
Schmidtke M; Wutzler P; Zieger R; Riabova OB; Makarov VA
Antiviral Res; 2009 Jan; 81(1):56-63. PubMed ID: 18840470
[TBL] [Abstract][Full Text] [Related]
11. Antiviral activity of substituted homoisoflavonoids on enteroviruses.
Tait S; Salvati AL; Desideri N; Fiore L
Antiviral Res; 2006 Dec; 72(3):252-5. PubMed ID: 16934879
[TBL] [Abstract][Full Text] [Related]
12. Antiviral activity and molecular features of benzimidazoles.
O'Sullivan DG; Ludlow C; Pantic D; Wallis AK
Antimicrob Agents Chemother (Bethesda); 1969; 9():153-9. PubMed ID: 4319306
[No Abstract] [Full Text] [Related]
13. Synthesis, structure and in vitro anti-human immunodeficiency virus activity of novel 3-methyl-1H,3H-thiazolo[3,4-a]benzimidazoles.
Chimirri A; Grasso S; Monforte AM; Monforte P; Rao A; Zappalà M; Bruno G; Nicolò F; Pannecouque C; Witvrouw M; De Clercq E
Antivir Chem Chemother; 1998 Sep; 9(5):431-8. PubMed ID: 9875396
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, structure-activity relationship and in vitro biological evaluation of N-arylethyl isoquinoline derivatives as Coxsackievirus B3 inhibitors.
Wang YX; Li YH; Li YH; Gao RM; Wang HQ; Liu YX; Gao LM; Lu QN; Jiang JD; Song DQ
Bioorg Med Chem Lett; 2011 Oct; 21(19):5787-90. PubMed ID: 21880491
[TBL] [Abstract][Full Text] [Related]
15. Antiviral and antiproliferative activity in vitro of some new benzimidazole derivatives.
Castelli M; Malagoli M; Lupo L; Riccomi TR; Casolari C; Cermelli C; Zanca A; Baggio G
Pharmacol Toxicol; 2001 Feb; 88(2):67-74. PubMed ID: 11169164
[TBL] [Abstract][Full Text] [Related]
16. QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration.
Song X; Liu Z; Wang H; Xin Y; Wang X; Chen J; Shi Y; Zhang C; Hui R
Exp Biol Med (Maywood); 2007 Dec; 232(11):1441-8. PubMed ID: 18040068
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and structure-activity relationships of pyrazolo[3,4-d]pyrimidines: a novel class of potent enterovirus inhibitors.
Chern JH; Shia KS; Hsu TA; Tai CL; Lee CC; Lee YC; Chang CS; Tseng SN; Shih SR
Bioorg Med Chem Lett; 2004 May; 14(10):2519-25. PubMed ID: 15109643
[TBL] [Abstract][Full Text] [Related]
18. Anti-HIV agents II. Synthesis and in vitro anti-HIV activity of novel 1H,3H-thiazolo[3,4-a]benzimidazoles.
Chimirri A; Grasso S; Monforte AM; Monforte P; Zappala M
Farmaco; 1991; 46(7-8):925-33. PubMed ID: 1686551
[TBL] [Abstract][Full Text] [Related]
19. Anti-HIV agents. III. Synthesis and in vitro anti-HIV activity of novel 1H,3H-thiazolo[3,4-a]imidazo[4,5-b]pyridines.
Chimirri A; Grasso S; Montforte AM; Monforte P; Zappalà M
Farmaco; 1994 May; 49(5):345-8. PubMed ID: 8080617
[TBL] [Abstract][Full Text] [Related]
20. The thiazolobenzimidazole TBZE-029 inhibits enterovirus replication by targeting a short region immediately downstream from motif C in the nonstructural protein 2C.
De Palma AM; Heggermont W; Lanke K; Coutard B; Bergmann M; Monforte AM; Canard B; De Clercq E; Chimirri A; Pürstinger G; Rohayem J; van Kuppeveld F; Neyts J
J Virol; 2008 May; 82(10):4720-30. PubMed ID: 18337578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
